Proapoptotic Bid is required for pulmonary fibrosis.

The molecular mechanisms of pulmonary fibrosis are poorly understood. Previous reports indicate that activation of TGF-beta1 is essential for the development of pulmonary fibrosis. Here, we report that the proapoptotic Bcl-2 family member Bid is required for the development of pulmonary fibrosis after the intratracheal instillation of bleomycin. Mice lacking Bid exhibited significantly less pulmonary fibrosis in response to bleomycin compared with WT mice. The attenuation in pulmonary fibrosis was observed despite similar levels of inflammation, lung injury, and active TGF-beta1 in bronchoalveolar lavage fluid 5 days after the administration of bleomycin in mice lacking Bid and in WT controls. Bleomycin induced similar levels cell death in vitro in alveolar epithelial cells isolated from WT and bid(-/-) mice. By contrast, alveolar epithelial cells from bid(-/-) mice were resistant to TGF-beta1-induced cell death. These results indicate that Bcl-2 family members are critical regulators for the development of pulmonary fibrosis downstream of TGF-beta1 activation.

[1]  J. Eisenbart,et al.  Bleomycin induces alveolar epithelial cell death through JNK-dependent activation of the mitochondrial death pathway. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[2]  G. Laurent,et al.  Pulmonary fibrosis: searching for model answers. , 2005, American journal of respiratory cell and molecular biology.

[3]  M. Kolb,et al.  Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. , 2005, American journal of respiratory and critical care medicine.

[4]  J. Eisenbart,et al.  Active transforming growth factor-β1 activates the procollagen I promoter in patients with acute lung injury , 2004, Intensive Care Medicine.

[5]  J. Milbrandt,et al.  Early Growth Response Gene 1–mediated Apoptosis Is Essential for Transforming Growth Factor β1–induced Pulmonary Fibrosis , 2004, The Journal of experimental medicine.

[6]  A. Roberts,et al.  Smad3 Null Mice Develop Airspace Enlargement and Are Resistant to TGF-β-Mediated Pulmonary Fibrosis1 , 2004, The Journal of Immunology.

[7]  D. Green,et al.  The Pathophysiology of Mitochondrial Cell Death , 2004, Science.

[8]  S. Korsmeyer,et al.  Cell Death Critical Control Points , 2004, Cell.

[9]  B. Uhal,et al.  Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice. , 2003, The American journal of pathology.

[10]  Y. Nagashima,et al.  Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lung prevents bleomycin-induced pulmonary fibrosis via a Fas-Fas ligand-independent pathway. , 2002, Human gene therapy.

[11]  P. Sime,et al.  A new direction in the pathogenesis of idiopathic pulmonary fibrosis? , 2001, Respiratory research.

[12]  G. Hunninghake,et al.  Idiopathic pulmonary fibrosis. , 2001, The New England journal of medicine.

[13]  Naftali Kaminski,et al.  TGF-β is a critical mediator of acute lung injury , 2001 .

[14]  D. Sheppard.  Pulmonary fibrosis: a cellular overreaction or a failure of communication? , 2001, The Journal of clinical investigation.

[15]  S. Korsmeyer,et al.  Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.

[16]  A. Pardo,et al.  Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy , 2001, Annals of Internal Medicine.

[17]  J. Tamaoki,et al.  The Fas/Fas-ligand system is not required for bleomycin-induced pulmonary fibrosis in mice. , 2000, American journal of respiratory and critical care medicine.

[18]  M. Matthay,et al.  The acute respiratory distress syndrome. , 1996, The New England journal of medicine.

[19]  Qingjian Wang,et al.  Reduction of bleomycin induced lung fibrosis by transforming growth factor β soluble receptor in hamsters , 1999, Thorax.

[20]  S. Korsmeyer,et al.  Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis , 1999, Nature.

[21]  S. Nagata,et al.  Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. , 1999, The Journal of clinical investigation.

[22]  N. Kaminski,et al.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.

[23]  M. Peter,et al.  Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. , 1998, Current opinion in immunology.

[24]  Xiaodong Wang,et al.  Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.

[25]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[26]  K. Kuwano,et al.  Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. , 1997, American journal of respiratory cell and molecular biology.

[27]  K. Csaky,et al.  Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. , 1997, The Journal of clinical investigation.

[28]  Xiaodong Wang,et al.  Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.

[29]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[30]  Xiaodong Wang,et al.  Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[31]  D. Hyde,et al.  Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. , 1993, Thorax.

[32]  I. Adamson,et al.  Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. , 1988, The American journal of pathology.